Resurgent Financial Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.43M Buy
50,987
+13,272
+35% +$353K 0.52% 46
2025
Q4
$939K Buy
37,715
+3,513
+10% +$88.6K 0.47% 55
2025
Q3
$871K Buy
34,202
+6,334
+23% +$156K 0.43% 61
2025
Q2
$676K Sell
27,868
-302
-1% -$7.04K 0.37% 73
2025
Q1
$714K Buy
28,170
+3,031
+12% +$79.3K 0.43% 65
2024
Q4
$667K Sell
25,139
-692
-3% -$18.8K 0.39% 68
2024
Q3
$748K Sell
25,831
-603
-2% -$17.6K 0.44% 68
2024
Q2
$740K Sell
26,434
-9,836
-27% -$271K 0.46% 63
2024
Q1
$1.01M Buy
36,270
+5,173
+17% +$144K 0.54% 54
2023
Q4
$895K Sell
31,097
-1,331
-4% -$40.2K 0.55% 41
2023
Q3
$1.08M Buy
32,428
+770
+2% +$27.2K 0.73% 27
2023
Q2
$1.16M Sell
31,658
-279
-0.9% -$10.9K 0.77% 31
2023
Q1
$1.3M Buy
31,937
+520
+2% +$22.5K 0.87% 26
2022
Q4
$1.61M Sell
31,417
-17,939
-36% -$860K 0.85% 23
2022
Q3
$2.16M Buy
49,356
+1,664
+3% +$80.9K 1.44% 14
2022
Q2
$2.5M Buy
47,692
+12,467
+35% +$635K 1.6% 9
2022
Q1
$1.82M Buy
35,225
+11,715
+50% +$608K 1.13% 17
2021
Q4
$1.39M Buy
+23,510
New +$1.16M 1.11% 21

Other funds holding PFE

Resurgent Financial Advisors's PFE Position: Q1 2026 in Review

Resurgent Financial Advisors increased its Pfizer (PFE) stake by 35% in Q1 2026, buying an estimated $353K and bringing the position to 50,987 shares worth $1.43M. The position accounts for 0.52% of the portfolio, ranked #46.

Resurgent Financial Advisors first reported a position in PFE in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.5M in Q2 2022. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Resurgent Financial Advisors held 50,987 shares of Pfizer worth $1.43M as of Q1 2026.
  • Resurgent Financial Advisors bought 13,272 Pfizer shares in Q1 2026, an estimated $353K.
  • Pfizer made up 0.52% of Resurgent Financial Advisors's portfolio in Q1 2026, its #46 holding.
  • Resurgent Financial Advisors first reported a position in Pfizer in Q4 2021 and has held it in 18 quarters since.
  • Resurgent Financial Advisors's Pfizer position peaked at $2.5M in Q2 2022.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Resurgent Financial Advisors's 13F filing for Q1 2026, filed 13 May 2026.